| 商品名称 | 适用类别 | 通用名称 | 活性成分 | 产品号 | 上市许可开发者/申请人/持有人 | 上市许可日期 | 许可状态 |
|---|---|---|---|---|---|---|---|
| Imaavy | Human | nipocalimab | nipocalimab | EMEA/H/C/006379 | Janssen Cilag International NV | 2025/11/28 | Authorised |
| Rivaroxaban Koanaa | Human | rivaroxaban | rivaroxaban | EMEA/H/C/006643 | Koanaa Healthcare GmbH | 2025/11/21 | Authorised |
| Brinsupri | Human | Brensocatib | Brensocatib monohydrate | EMEA/H/C/005820 | Insmed Netherlands B.V. | 2025/11/18 | Authorised |
| Kefdensis | Human | denosumab | denosumab | EMEA/H/C/006490 | Stada Arzneimittel AG | 2025/11/17 | Authorised |
| Zvogra | Human | denosumab | denosumab | EMEA/H/C/006552 | Stada Arzneimittel AG | 2025/11/17 | Authorised |
| Denosumab Intas | Human | denosumab | denosumab | EMEA/H/C/006797 | Intas Third Party Sales 2005 S.L. | 2025/11/17 | Authorised |
| Lynkuet | Human | elinzanetant | elinzanetant | EMEA/H/C/006298 | Bayer AG | 2025/11/17 | Authorised |
| Usgena | Human | ustekinumab | ustekinumab | EMEA/H/C/006667 | Stada Arzneimittel AG | 2025/11/17 | Authorised |
| Gobivaz | Human | golimumab | golimumab | EMEA/H/C/006560 | Advanz Pharma Limited | 2025/11/17 | Authorised |
| Macitentan AccordPharma | Human | macitentan | macitentan | EMEA/H/C/006523 | Accord Healthcare | 2025/09/24 | Authorised |
| Macitentan Accord | Human | macitentan | macitentan | EMEA/H/C/006524 | Accord Healthcare | 2025/09/24 | Authorised |
| Kisunla | Human | donanemab | donanemab | EMEA/H/C/006024 | Eli Lilly Nederland B.V. | 2025/09/24 | Authorised |
| Bildyos | Human | denosumab | denosumab | EMEA/H/C/006434 | Sciencepharma Sp. z o.o | 2025/09/17 | Authorised |
| Tryngolza | Human | olezarsen | olezarsen sodium | EMEA/H/C/006477 | Swedish Orphan Biovitrum AB (publ) | 2025/09/17 | Authorised |
| Bilprevda | Human | denosumab | denosumab | EMEA/H/C/006435 | Sciencepharma Sp. z o.o | 2025/09/17 | Authorised |
| Ekterly | Human | sebetralstat | sebetralstat | EMEA/H/C/006211 | Kalvista Pharmaceuticals (Ireland) Limited | 2025/09/17 | Authorised |
| Usrenty | Human | ustekinumab | ustekinumab | EMEA/H/C/006794 | Biosimilar Collaborations Ireland Limited | 2025/09/17 | Authorised |
| Voranigo | Human | vorasidenib | vorasidenib | EMEA/H/C/006284 | Les Laboratoires Servier | 2025/09/17 | Authorised |
| Romvimza | Human | vimseltinib | vimseltinib dihydrate | EMEA/H/C/006363 | Deciphera Pharmaceuticals (Netherlands) B.V. | 2025/09/17 | Authorised |
| Eyluxvi | Human | aflibercept | aflibercept | EMEA/H/C/006282 | Biolitec pharma Limited Zweigniederlassung Jena | 2025/09/15 | Authorised |
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
药物在线相关数据库
